Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)
NCT ID: NCT00778570
Last Updated: 2014-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2007-02-28
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The working hypothesis is that there will be no difference in clinical outcomes between patients treated with LASIK or ASA.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This review is intended to study whether LASIK is equal in visual outcome (null hypothesis), more effective (alternate hypothesis 1) or less effective (alternate hypothesis 2) than ASA in clinical outcome up to one year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASA
Participants treated for Excimer laser vision correction using Advanced Surface Ablation (ASA).
No interventions assigned to this group
LASIK
Participants treated for Excimer laser vision correction using Laser-Assisted In Situ Keratomileusis (LASIK)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George Mintsioulis, MD
Role: PRINCIPAL_INVESTIGATOR
University of Ottawa Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ottawa Eye Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006800-01H
Identifier Type: -
Identifier Source: org_study_id